Neuland Laboratories Limited Stock price NSE India S.E.

Equities

NEULANDLAB

INE794A01010

Pharmaceuticals

Market Closed - NSE India S.E. 08:02:00 2024-03-28 am EDT 5-day change 1st Jan Change
6,322 INR -0.59% Intraday chart for Neuland Laboratories Limited +4.64% +19.48%
Sales 2024 * 15.93B 191M Sales 2025 * 17.09B 205M Capitalization 80.59B 967M
Net income 2024 * 3.11B 37.28M Net income 2025 * 3.19B 38.24M EV / Sales 2024 * 5.06 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 4.72 x
P/E ratio 2024 *
26.1 x
P/E ratio 2025 *
25.4 x
Employees 1,554
Yield 2024 *
-
Yield 2025 *
-
Free-Float 62.12%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.59%
1 week+4.64%
Current month-11.73%
1 month-10.98%
3 months+19.26%
6 months+66.47%
Current year+19.48%
More quotes
1 week
6 234.05
Extreme 6234.05
6 500.00
1 month
5 549.85
Extreme 5549.85
7 303.25
Current year
5 021.10
Extreme 5021.1
7 318.30
1 year
1 782.50
Extreme 1782.5
7 318.30
3 years
967.00
Extreme 967
7 318.30
5 years
245.75
Extreme 245.75
7 318.30
10 years
245.00
Extreme 245
7 318.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 01-12-31
Director of Finance/CFO - 22-11-22
Chief Tech/Sci/R&D Officer - Nov. 21
Members of the board TitleAgeSince
Director/Board Member 78 22-10-30
Director/Board Member 80 19-02-11
Director/Board Member 85 99-07-23
More insiders
Date Price Change Volume
24-03-28 6,322 -0.59% 16,249
24-03-27 6,360 -1.48% 17,882
24-03-26 6,455 +1.10% 15,035
24-03-22 6,385 +5.68% 33,954
24-03-21 6,042 +1.78% 47,420

Delayed Quote NSE India S.E., March 28, 2024 at 08:02 am EDT

More quotes
Neuland Laboratories Limited is an India-based company, which is engaged in manufacturing and selling of bulk drugs. The Company caters to both domestic and international markets. It manufactures active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs. The Company provide solutions across the full range of the pharmaceutical industry’s chemistry requirements, from the synthesis of library compounds to supplying NCEs and advanced intermediates at various stages in the clinical life cycle, as well as commercial launch. The Company operates through a single segment, manufacture of active pharmaceutical ingredients and allied services. The Company has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its products and services include Levetiracetam, Mirtazapine, Ciprofloxacin, Enalapril, Sotalol, Labetalol and Custom Manufacturing Services.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6,281 INR
Average target price
7,500 INR
Spread / Average Target
+19.40%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Neuland Laboratories Limited
  4. Stock Neuland Laboratories Limited - NSE India S.E.